Kalmer, Milena
Pannen, Kristina
Lemanzyk, Rebecca
Wirths, Chiara
Baumeister, Julian
Maurer, Angela
Kricheldorf, Kim
Schifflers, Joelle
Gezer, Deniz
Isfort, Susanne
Brümmendorf, Tim H.
Koschmieder, Steffen
Chatain, Nicolas http://orcid.org/0000-0003-4485-3120
Funding for this research was provided by:
Novartis Pharma (HINC-212)
Deutsche Forschungsgemeinschaft (KO 2155/6-1, AOBJ 636363)
RWTH Aachen University
Article History
Received: 24 June 2022
Accepted: 1 October 2022
First Online: 21 October 2022
Declarations
:
: Biomaterial samples were provided by the RWTH centralized Biomaterial Bank Aachen (RWTH cBMB, Aachen, Germany) in accordance with the regulations of the biomaterial bank and the approval of the ethics committee (EK 127/12) of the medical faculty, RWTH Aachen.
: See “Ethics approval.”
: The patients’ written informed consent includes a statement that their data will be published.
: S. K. reports funding from Novartis, Bristol-Myers Squibb, and Janssen/Geron; advisory board honoraria from Pfizer, Incyte, Ariad, Novartis, AOP Pharma, BMS, Celgene, Geron, Janssen, CTI, Roche, Baxalta, and Sanofi; patent for BET inhibitor at RWTH Aachen University; honoraria from Novartis, BMS, Celgene, Geron, Janssen, Pfizer, Incyte, Ariad, Shire, Roche, and AOP Pharma; and other financial support (e.g., travel support) from Alexion, Novartis, BMS, Incyte, Ariad, AOP Pharma, Baxalta, CTI, Pfizer, Sanofi, Celgene, Shire, Janssen, Geron, Abbvie, and Karthos. T. H. B. served as a consultant for Janssen, Merck, Novartis, and Pfizer; received research funding from Novartis and Pfizer; and received honorarium from Pfizer. D. G. reports advisory board honoraria from AMGEN, Celgene, TAKEDA, and Janssen; served as Invited Speaker for AMGEN, Celgene, BMS, and TAKEDA; and received other financial support (e.g., travel support) from TAKEDA, Celgene, and AMGEN. S. I. reports honoraria and membership on entity’s Board of Directors or advisory committees from Ariad, Novartis, and Pfizer as well as honoraria from BMS and travel reimbursement from Alexion, Amgen, Hexal, Mundipharma, Pfizer, Roche, and Novartis.